Yes agree. In fact Gourlay had to effectively repeat the last trial as the previous trials weren't sufficient. The previous ceo did a great job getting this company to where it needed to after many years of development. Gourlay has brought other bio tech to fruition - can't remember the nane but got it to $3.5b market cap and that's what we need. A finisher.
ACW Price at posting:
8.5¢ Sentiment: Buy Disclosure: Held
